Market Cap 6.73M
Revenue (ttm) 10,000.00
Net Income (ttm) -6.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -60,000.00%
Debt to Equity Ratio 0.00
Volume 64,216,102
Avg Vol 11,722,075
Day's Range N/A - N/A
Shares Out 4.74M
Stochastic %K 61%
Beta 1.94
Analysts Sell
Price Target $20.00

Company Profile

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized super...

Industry: Biotechnology
Sector: Healthcare
Phone: 480 399 2822
Address:
211 East Osborn Road, Phoenix, United States
Nexttick
Nexttick Aug. 10 at 1:02 AM
$CELZ $ZYBT $ZJYL $WFF Who’s ready to bank this week? 🏦 👀
1 · Reply
Nexttick
Nexttick Aug. 10 at 1:01 AM
$CELZ $2.00++ PT
0 · Reply
IntentionalTrades
IntentionalTrades Aug. 10 at 12:46 AM
$CELZ Still have some runners here
0 · Reply
AlertsAndNews
AlertsAndNews Aug. 9 at 11:24 PM
$HTZ $CELZ $ENSC $WWR $AMIX New week new plays. Can't wait for tomorrow! lets do it again!
0 · Reply
johnrivers0110
johnrivers0110 Aug. 9 at 10:52 PM
$SOAR 🔺🐇🚀🚀🚀🚀🚀🚀 $CELZ 🔺🚀🚀🚀 $DJT $AMC $TSLA The FiB 🔺
0 · Reply
FroNOBaggins
FroNOBaggins Aug. 9 at 10:07 PM
$CELZ Management/directors reported beneficial ownership of just 49,454 shares as of April, equal to about 0.75% of today’s OS if unchanged. Even that overstates their personal common-stock exposure: the figure includes options, warrants and 22,695 shares owned by affiliated company Creative Medical Holdings (CMH), which are attributed to Warbington because he is CMH’s CEO. Meanwhile, Warbington, Dickerson and the three directors received about $3.005M in disclosed compensation in 2024-25, roughly 32% of CELZ’s current ~$9.36M market cap at $1.42. Long-term shareholders have absorbed reverse splits and substantial dilution. Before giving management authority for another 75M shares, it is fair to ask how closely management’s own financial interests are tied to the common shareholders being asked to take that risk.
0 · Reply
WillyT2
WillyT2 Aug. 9 at 9:54 PM
$ZJYL TapeGrid got it #1💪 $CLRO $AIFA $CELZ $SOAR
0 · Reply
PharmaExpert
PharmaExpert Aug. 9 at 6:40 PM
$CELZ did great for 9700 followers this week!🔥
0 · Reply
Zeestallion
Zeestallion Aug. 9 at 6:25 PM
$VIVS 🍋 💦 This was the key imo $CELZ $CPOP $HCWC $HTZ
0 · Reply
Modo6177
Modo6177 Aug. 9 at 6:24 PM
$CELZ is it me or all those bear flags in the charts don’t mean much…?
0 · Reply
Latest News on CELZ
Creative Medical Technology Holdings Issues Mid-Year Update

Jul 1, 2026, 9:00 AM EDT - 5 weeks ago

Creative Medical Technology Holdings Issues Mid-Year Update


Creative Medical files to sell 3.05M shares of common stock

2026-06-25T20:10:16.000Z - 6 weeks ago

Creative Medical files to sell 3.05M shares of common stock


Creative Medical expands ADAPT trial under new FDA clearance

2026-06-22T13:55:45.000Z - 6 weeks ago

Creative Medical expands ADAPT trial under new FDA clearance


Creative Medical achieves second WHO INN milestone

2026-02-10T14:06:26.000Z - 6 months ago

Creative Medical achieves second WHO INN milestone


Creative Medical launches Biodefense Inc. Veterans Initiative

2025-10-30T13:20:14.000Z - 10 months ago

Creative Medical launches Biodefense Inc. Veterans Initiative


Creative Medical issues letter to shareholders

2025-10-27T12:30:51.000Z - 10 months ago

Creative Medical issues letter to shareholders


Creative Medical Technology Holdings Issues Letter to Shareholders

Oct 27, 2025, 8:15 AM EDT - 10 months ago

Creative Medical Technology Holdings Issues Letter to Shareholders


Creative Medical Technology Holdings Provides Corporate Update

Jul 10, 2024, 8:30 AM EDT - 2 years ago

Creative Medical Technology Holdings Provides Corporate Update


Nexttick
Nexttick Aug. 10 at 1:02 AM
$CELZ $ZYBT $ZJYL $WFF Who’s ready to bank this week? 🏦 👀
1 · Reply
Nexttick
Nexttick Aug. 10 at 1:01 AM
$CELZ $2.00++ PT
0 · Reply
IntentionalTrades
IntentionalTrades Aug. 10 at 12:46 AM
$CELZ Still have some runners here
0 · Reply
AlertsAndNews
AlertsAndNews Aug. 9 at 11:24 PM
$HTZ $CELZ $ENSC $WWR $AMIX New week new plays. Can't wait for tomorrow! lets do it again!
0 · Reply
johnrivers0110
johnrivers0110 Aug. 9 at 10:52 PM
$SOAR 🔺🐇🚀🚀🚀🚀🚀🚀 $CELZ 🔺🚀🚀🚀 $DJT $AMC $TSLA The FiB 🔺
0 · Reply
FroNOBaggins
FroNOBaggins Aug. 9 at 10:07 PM
$CELZ Management/directors reported beneficial ownership of just 49,454 shares as of April, equal to about 0.75% of today’s OS if unchanged. Even that overstates their personal common-stock exposure: the figure includes options, warrants and 22,695 shares owned by affiliated company Creative Medical Holdings (CMH), which are attributed to Warbington because he is CMH’s CEO. Meanwhile, Warbington, Dickerson and the three directors received about $3.005M in disclosed compensation in 2024-25, roughly 32% of CELZ’s current ~$9.36M market cap at $1.42. Long-term shareholders have absorbed reverse splits and substantial dilution. Before giving management authority for another 75M shares, it is fair to ask how closely management’s own financial interests are tied to the common shareholders being asked to take that risk.
0 · Reply
WillyT2
WillyT2 Aug. 9 at 9:54 PM
$ZJYL TapeGrid got it #1💪 $CLRO $AIFA $CELZ $SOAR
0 · Reply
PharmaExpert
PharmaExpert Aug. 9 at 6:40 PM
$CELZ did great for 9700 followers this week!🔥
0 · Reply
Zeestallion
Zeestallion Aug. 9 at 6:25 PM
$VIVS 🍋 💦 This was the key imo $CELZ $CPOP $HCWC $HTZ
0 · Reply
Modo6177
Modo6177 Aug. 9 at 6:24 PM
$CELZ is it me or all those bear flags in the charts don’t mean much…?
0 · Reply
Zeestallion
Zeestallion Aug. 9 at 6:05 PM
$VIVS 🍋 💦 💣🚀 $CELZ $CPOP $HCWC $HTZ
1 · Reply
Zeestallion
Zeestallion Aug. 9 at 5:58 PM
$VIVS 🔥 VIVS very strong results here (all 90% plus) $CELZ $CPOP $HCWC $HTZ
0 · Reply
Zeestallion
Zeestallion Aug. 9 at 5:56 PM
$VIVS 🔥 Listen folks I’m pounding the table on VIVS just like i did when REPL was in the $1’s as you can see below Look where REPL is at now NOW im POUNDING the table on VIVS Watch and learn 👇 screenshot 👇 $CELZ $CPOP $HCWC $HTZ
0 · Reply
Zeestallion
Zeestallion Aug. 9 at 5:46 PM
$VIVS Load up folks 🍋💦 👇 This could be the next XHLD 👇 $CELZ $CPOP $HCWC $HTZ https://www.quiverquant.com/news/VivoSim+regains+Nasdaq+compliance+after+%2410.1+million+cash+update
0 · Reply
AlphaOmegas
AlphaOmegas Aug. 9 at 5:14 PM
$AIFA ticker to watch Monday, don't forget to put this on ur watch! $CELZ $VIVS $YJ
0 · Reply
idkmikes57
idkmikes57 Aug. 9 at 4:07 PM
$CELZ i just don't see why.This is not a thirty dollar stock with reset news something's up beware!
1 · Reply
Martian_Paradisee
Martian_Paradisee Aug. 9 at 4:02 PM
$CELZ Borrow rate: 415.75% Short interest: 41% Interesting!!
1 · Reply
FroNOBaggins
FroNOBaggins Aug. 9 at 2:25 PM
$CELZ ~3/31/26 CELZ had 3,696,668 shares outstanding. 8/7/26 CELZ had 6,592,557. That's a ~78% increase in about 4 months. Based on the latest filings, another ~8.61M shares remain underlying outstanding warrants, including the 5.58M new $1.60 warrants awaiting shareholder approval. If all remaining warrants were eventually exercised for cash, they could theoretically generate roughly $18.9M in gross proceeds. So POTENTIAL share count if all remaining warrants were exercised is ~15.20M, which would still leave CELZ with roughly 9.8M AS to do as they wish with under the CURRENT 25M authorization. CELZ reported $8.7M cash at June 30. Using that as a static starting point, full cash warrant exercise would imply roughly $27.6M before subsequent cash burn. So why does management want another 75M authorized shares?
0 · Reply
FroNOBaggins
FroNOBaggins Aug. 9 at 2:06 PM
$CELZ In March, CELZ said it expected existing cash to cover anticipated operating costs and capital expenditure reqs through at least March 2027 (while acknowledging more capital would eventually be needed for clinical development). On June 22, CELZ said the 15-patient ADAPT expansion could be completed using existing resources and would support Phase 3 discussions. After the June 30 warrant deal, CELZ said it was not compelled to pursue dilution simply to “keep the lights on.” Why, then, was it necessary to reprice 2.79M warrants from $2.86 to $1.60, issue 5.58M new $1.60 warrants, and seek authorization for 75M additional shares? How much money is needed to get from where ADAPT is today to an actual pivotal Phase 3 trial, and what portion of that pathway is currently funded?
0 · Reply
PharmaExpert
PharmaExpert Aug. 9 at 12:06 PM
0 · Reply
TALENT_ON_LOAN_FROM_GOD
TALENT_ON_LOAN_FROM_GOD Aug. 9 at 11:40 AM
$CELZ SET YOUR SELLS OVER $7 $CPOP $HCWC $HTZ $VIVS https://www.sec.gov/Archives/edgar/data/1187953/000147793226004302/celz_def14a.htm
0 · Reply
TALENT_ON_LOAN_FROM_GOD
TALENT_ON_LOAN_FROM_GOD Aug. 9 at 9:51 AM
$CELZ I DONT BLAME YOU SHORTY👀I WOULD BE SCARED SHHHHTLESS TOO 🤓☝️ $AMIX $ENSC $HTZ $WWR
0 · Reply